Women's Perspectives on Female-Initiated Barrier Methods for the Prevention of HIV in the Context of Methamphetamine Use and Partner Violence
| Autor: | Julie N. Bergmann, Jennifer L. Syvertsen, Jamila K. Stockman, Angela M. Robertson, Lawrence A. Palinkas, Natasha Ludwig-Barron |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
Adult
Male Sexual partner Health (social science) Substance-Related Disorders Poison control HIV Infections Context (language use) Violence California Article Methamphetamine Syndemic Anti-Infective Agents Acquired immunodeficiency syndrome (AIDS) Risk Factors Maternity and Midwifery Humans Medicine Women Condoms Female Crime Victims Reproductive health business.industry Sex Offenses Public Health Environmental and Occupational Health Obstetrics and Gynecology Middle Aged medicine.disease United States Substance abuse Sexual Partners Patient Satisfaction Spouse Abuse Vagina Female Sex offense business Attitude to Health Social psychology Clinical psychology |
| Zdroj: | Women's Health Issues. 24:e397-e405 |
| ISSN: | 1049-3867 |
| DOI: | 10.1016/j.whi.2014.04.001 |
| Popis: | Background Female-initiated barrier methods for the prevention of HIV may be an effective alternative for drug-using women who are unable to negotiate safe sex, often as a result of physical and/or sexual partner violence. Methods Utilizing a SAVA (substance abuse, violence, and AIDS) syndemic framework, we qualitatively examined perspectives on female condoms and vaginal microbicides among 18 women with histories of methamphetamine abuse and partner violence in San Diego, California. Findings Most women were not interested in female condoms owing to perceived discomfort, difficulty of insertion, time-intensive effort, and unappealing appearance. Alternatively, most women viewed vaginal microbicides as a useful method. Positive aspects included convenience, ability to disguise as a lubricant, and a sense of control and empowerment. Concerns included possible side effects, timing of application, and unfavorable characteristics of the gel. Acceptability of female-initiated barrier methods was context dependent (i.e., partner type, level of drug use and violence that characterized the sexual relationship). Conclusions Findings indicate that efforts are needed to address barriers identified for vaginal microbicides to increase its uptake in future HIV prevention trials and marketing of future Food and Drug Administration-approved products. Strategies should address gender-based inequalities (e.g., partner violence) experienced by drug-using women and promote female empowerment. Education on female-initiated barrier methods is also needed for women who use drugs, as well as health care providers and other professionals providing sexual health care and contraception to women with histories of drug use and partner violence. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect